https://newsletter.glp1studio.com/p/tirzepatide-now-has-to-beat-cpapGLP-1 Studioen2026-09-30T17:00:00+00:00Tirzepatide now has to beat CPAP machines, not just placebohttps://newsletter.glp1studio.com/p/new-york-wants-insurers-to-stop-owningGLP-1 Studioen2026-09-30T17:00:00+00:00New York wants insurers to stop owning their own middlemenhttps://newsletter.glp1studio.com/p/indias-counterfeit-mounjaro-tradeGLP-1 Studioen2026-09-30T17:00:00+00:00India's counterfeit Mounjaro trade is booming, and buyers can't tellhttps://newsletter.glp1studio.com/p/doj-charges-two-men-over-counterfeitGLP-1 Studioen2026-09-30T17:00:00+00:00DOJ charges two men over counterfeit Ozempic shipped from China